Business
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that
About this update from Tandem Diabetes Care, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 4:40pm Eastern Time (1:40pm Pacific Time).\n\n\nThe Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\n\n\nAbout Tandem Diabetes Care, Inc.\n\n\nTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.\n\n\nTandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\n\n\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.\nFollow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230420005072/en/\n\nMedia Contact:\n858-255-6388\[email protected]\n\n\nInvestor Contact:\n858-366-6900\[email protected]\n\n\nSource: Tandem Diabetes Care, Inc.","length":4571,"tagName":"div"}]